엘텍파마켐

비상장계속사업자

L-TEC PHARMACHEM CO.,LTD.

김도형

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

엘텍파마켐

Business Reg. No. 1058634546 · CEO 김도형

I.Investment Overview

Target엘텍파마켐 (1058634546)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명엘텍파마켐
영문명L-TEC PHARMACHEM CO.,LTD.
대표자김도형
사업자등록번호1058634546
법인등록번호1101112411819
설립일2002.01.03
종업원수27명

V.Workforce

27

Current headcount · 2026.06 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW369.82021391.72022283.62023289.820243142025
영업이익100M KRW16.12021-5.42022-3.220230.220244.82025
순이익100M KRW112021-5.32022-4.72023-2.120241.32025
Item20252024202320222021
자산총계164.2억원169.3억원146.4억원176.3억원196.9억원
부채총계68.8억원75.2억원50.4억원75.5억원90.8억원
자본총계95.3억원94억원96.1억원100.8억원106.1억원
매출액314억원289.8억원283.6억원391.7억원369.8억원
영업이익4.8억원1,538만원-3.2억원-5.4억원16.1억원
순이익1.3억원-2.1억원-4.7억원-5.3억원11억원

VII.Financial Ratios

FY2025 basis

1.54%

영업이익률

0.41%

순이익률

0.79%

ROA

1.36%

ROE

72.22%

부채비율

58.07%

자기자본비율

VIII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

엘텍파마켐 투심보고서 | Alpha Lenz